NcoI TNF-β gene polymorphism and TNF expression are associated with an increased risk of developing Barrett's esophagus and esophageal adenocarcinoma

Scandinavian Journal of Gastroenterology

Volumn 47, Issue 4, 2012, Pages 378-386

  Menke, Vivianda ^a   Van Zoest, Katinka P M ^a   Moons, Leon M G ^a   Hansen, Bettina ^a   Pot, Raymond G J ^a   Siersema, Peter D ^a,b   Kusters, Johannes G ^a,b   Kuipers, Ernst J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Barrett's esophagus; chronic inflammation; esophageal adenocarcinoma; reflux esophagitis; tumor necrosis factor (TNF)

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR;

ARTICLE; BARRETT ESOPHAGUS; CAUCASIAN; CONTROLLED STUDY; CYTOKINE RELEASE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS BIOPSY; FEMALE; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; BARRETT ESOPHAGUS; CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; COHORT STUDIES; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEX FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84858684216     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2011.650192     Document Type: Article

References (31)

1. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. Jama 1991;265:1287-9.
2. Hamilton SR, Smith RR. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol 1987;87:301-12. (Pubitemid 17046980)
3. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31. (Pubitemid 29142625)
4. Izzo JG, Luthra R, Wu TT, et al. Molecular mechanisms in Barrett's metaplasia and its progression. Semin Oncol 2007;34(2 Suppl 1):S2-6. (Pubitemid 46590361)
5. Balkwill F, Coussens LM. Cancer: an inflammatory link. Nature 2004;431:405-6. (Pubitemid 39329565)
6. Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 2004;4:11-22. (Pubitemid 38111131)
7. Komori A, Yatsunami J, Suganuma M, et al. Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation. Cancer Res 1993;53:1982-5. (Pubitemid 23145713)
8. Hamaguchi M, Fujiwara Y, Takashima T, et al. Increased expression of cytokines and adhesion molecules in rat chronic esophagitis. Digestion 2003;68:189-97. (Pubitemid 38250508)
9. Schmitz H, Fromm M, Bentzel CJ, et al. Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J Cell Sci 1999;112:137-46. (Pubitemid 29043841)
10. Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 1996;334:1717-25. (Pubitemid 26193625)
11. Bouma G, Crusius JB, Oudkerk Pool M, et al. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 1996;43:456-63. (Pubitemid 26104933)
12. Messer G, Spengler U, Jung MC, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 1991;173:209-19.
13. Li C, Xia B, Yang Y, Li J, Xia HH. TNF gene polymorphisms and Helicobacter Pylori infection in gastric carcinogenesis in Chinese population. Am J Gastroenterol 2005;100:290-4.
14. Lanas A, Garcia-Gonzalez MA, Santolaria S, et al. TNF and LTA gene polymorphisms reveal different risk in gastric and duodenal ulcer patients. Genes Immun 2001;2:415-21. (Pubitemid 33674260)
15. Bronstein M, Pisante A, Yakir B, Darvasi A. Type 2 diabetes susceptibility loci in the Ashkenazi Jewish population. Hum Genet 2008;124:101-4.
16. Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 2002;11:235-56. (Pubitemid 34951272)
17. van Blankenstein M, Looman CW, Johnston BJ, Caygill CP. Age and sex distribution of the prevalence of Barrett's esophagus found in a primary referral endoscopy center. Am J Gastroenterol 2005;100:568-76. (Pubitemid 40487554)
18. Hameeteman W, TytgatGN,HouthoffHJ, van den Tweel JG. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989;96:1249-56. (Pubitemid 19126659)
19. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994;25:982-93. (Pubitemid 24313642)
20. Chow WH, Finkle WD,McLaughlin JK, Frankl H, Ziel HK, Fraumeni JF Jr. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. Jama 1995;274:474-7.
21. Fitzgerald RC, Onwuegbusi BA, Bajaj-Elliott M, Saeed IT, Burnham WR, Farthing MJ. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut 2002;50:451-9. (Pubitemid 34638860)
22. Moons LM, Kusters JG, Bultman E, et al. Barrett's oesophagus is characterized by a predominantly humoral inflammatory response. J Pathol 207:269-76.
23. MoonsLM,Kusters JG, vanDelftJH, et al.Apro-inflammatory genotype predisposes to Barrett's esophagus. Carcinogenesis 2008;29:926-31. (Pubitemid 351982235)
24. Tselepis C, Perry I, Dawson C, et al. Tumour necrosis factor-alpha in Barrett's oesophagus: a potential novel mechanism of action. Oncogene 2002;21:6071-81.
25. Wilson AG, di Giovine FS, Duff GW. Genetics of tumour necrosis factor-alphainautoimmune, infectious, and neoplastic diseases. J Inflamm 1995;45:1-12.
26. Eksteen JA, Scott PA, Perry I, Jankowski JA. Inflammation promotes Barrett's metaplasia and cancer: a unique role for TNFalpha. Eur J Cancer Prev 2001;10:163-6. (Pubitemid 32291638)
27. The International HapMap Project. Nature 2003;426:789-96.
28. Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 1997;26:487-94. (Pubitemid 27453229)
29. Wong A, Fitzgerald RC. Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma. Clin Gastroenterol Hepatol 2005;3:1-10. (Pubitemid 40092937)
30. Hosch SB, Izbicki JR, Pichlmeier U, et al. Expression and prognostic significance of immunoregulatory molecules in esophageal cancer. Int J Cancer 1997;74:582-7. (Pubitemid 28037498)
31. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70. (Pubitemid 30046295)